A Global pharmaceutical company that produces high quality affordable medicines for the international market.
Our client had experienced high turnover and was facing pressure from investors to meet tight deadlines and achieve financial milestones. Underdeveloped processes and inadequate reporting structures limited the organization’s ability to meet internal KPIs and effectively execute procurement strategies. Additionally, a lack of clearly defined roles and accountabilities meant that this organization would be unable to meet new regulatory compliance changes, especially with their proposed move to third-party manufacturing.
Our team worked closely with this organization to understand their current state and the issues impacting frontline employees in the execution of their work. We also examined the client’s organizational structure to define where the lack of accountabilities and responsibilities had led to substandard execution. In addition, we assessed third-party manufacturing options. Several opportunities were identified, and the following initiatives were implemented:
As result of this initiative, this organization enjoyed both immediate and long-term financial and strategic benefits: